Literature DB >> 17553565

Molecular genetic analysis of Hungarian patients with the hyper-immunoglobulin M syndrome.

Melinda Erdos1, Gabriella Lakos, Beáta Dérfalvi, Luigi D Notarangelo, Anne Durandy, László Maródi.   

Abstract

We have identified 9 disease-causing mutations in 18 hyper-immunoglobulin M (HIGM) syndrome patients from ten unrelated Hungarian families. CD40L mutation resulted in X-linked combined immunodeficiency in 11 patients (6 families) and AICDA mutation caused autosomal recessive HIGM characterized by B cell immunodeficiency in 5 patients (3 families). Two brothers with a genetically undefined form of HIGM and clinical manifestations of B cell deficiency were also included in this study. B cells from these two patients had defective CSR and skewed pattern of somatic hypermutation. Altogether, a novel CD40L truncation mutation (c.470 delA) and a new missense AICDA mutation (p.E58K) were identified. Carrier status was defined in 13 clinically healthy individuals allowing prenatal genetic testing that was performed in two affected families. This is the first comprehensive overview of molecular genetic features of Hungarian patients with HIGM syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553565     DOI: 10.1016/j.molimm.2007.04.014

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  3 in total

1.  First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.

Authors:  Otavio Cabral-Marques; Stefanie Klaver; Lena F Schimke; Évelyn H Ascendino; Taj Ali Khan; Paulo Vítor Soeiro Pereira; Angela Falcai; Alexander Vargas-Hernández; Leopoldo Santos-Argumedo; Liliana Bezrodnik; Ileana Moreira; Gisela Seminario; Daniela Di Giovanni; Andrea Gómez Raccio; Oscar Porras; Cristina Worm Weber; Janaíra Fernandes Ferreira; Fabiola Scancetti Tavares; Elisa de Carvalho; Claudia França Cavalcante Valente; Gisele Kuntze; Miguel Galicchio; Alejandra King; Nelson Augusto Rosário-Filho; Milena Baptistella Grota; Maria Marluce dos Santos Vilela; Regina Sumiko Watanabe Di Gesu; Simone Lima; Leiva de Souza Moura; Eduardo Talesnik; Eli Mansour; Pérsio Roxo-Junior; Juan Carlos Aldave; Ekaterine Goudouris; Fernanda Pinto-Mariz; Laura Berrón-Ruiz; Tamara Staines-Boone; Wilmer O Córdova Calderón; María del Carmen Zarate-Hernández; Anete S Grumach; Ricardo Sorensen; Anne Durandy; Troy R Torgerson; Beatriz Tavares Costa Carvalho; Francisco Espinosa-Rosales; Hans D Ochs; Antonio Condino-Neto
Journal:  J Clin Immunol       Date:  2014-01-09       Impact factor: 8.317

2.  CD40 Ligand Deficiency in Latin America: Clinical, Immunological, and Genetic Characteristics.

Authors:  Tábata Takahashi França; Lucila Akune Barreiros; Ranieri Coelho Salgado; Sarah Maria da Silva Napoleão; Lillian Nunes Gomes; Janáira Fernandes Severo Ferreira; Carolina Prando; Cristina Worm Weber; Regina Sumiko Watanabe Di Gesu; Cecilia Montenegro; Carolina Sanchez Aranda; Gisele Kuntze; Aidé Tamara Staines-Boone; Edna Venegas-Montoya; Juan Carlos Aldave Becerra; Liliana Bezrodnik; Daniela Di Giovanni; Ileana Moreira; Gisela Analia Seminario; Andrea Cecilia Gómez Raccio; Mayra de Barros Dorna; Nelson Augusto Rosário-Filho; Herberto Jose Chong-Neto; Elisa de Carvalho; Milena Baptistella Grotta; Julio Cesar Orellana; Miguel Garcia Dominguez; Oscar Porras; Laura Sasia; Karina Salvucci; Emilio Garip; Luiz Fernando Bacarini Leite; Wilma Carvalho Neves Forte; Fernanda Pinto-Mariz; Ekaterini Goudouris; María Enriqueta Nuñez Nuñez; Magdalena Schelotto; Laura Berrón Ruiz; Diana Inés Liberatore; Hans D Ochs; Otavio Cabral-Marques; Antonio Condino-Neto
Journal:  J Clin Immunol       Date:  2022-01-04       Impact factor: 8.317

3.  A delayed diagnosis of X-linked hyper IgM syndrome complicated with toxoplasmic encephalitis in a child: A case report and literature review.

Authors:  Xiaoliang Liu; Kaiyu Zhou; Dan Yu; Xiaotang Cai; Yimin Hua; Hui Zhou; Chuan Wang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.